The Chief Operating Officer of Columbia Care (Other OTC: CCHWF) is Selling Shares

By Carrie Williams

Today, the Chief Operating Officer of Columbia Care (CCHWFResearch Report), David Hart, sold shares of CCHWF for $66.52K.

In addition to David Hart, 7 other CCHWF executives reported Sell trades in the last month. Over the last month, David Hart has reported another 4 Sell trades on CCHWF for a total of $612.2K.

See today’s analyst top recommended stocks >>

Based on Columbia Care’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $48.7 million and GAAP net loss of -$10,855,000. In comparison, last year the company earned revenue of $22.12 million and had a GAAP net loss of $18.26 million. The company has a one-year high of $6.63 and a one-year low of $0.78. Currently, Columbia Care has an average volume of 426.17K.

Based on 5 analyst ratings, the analyst consensus is Strong Buy with an average price target of $9.30, reflecting a -27.7% downside. One of the top 25 analysts, according to, recently recommended Buy CCHWF with a $13.00 price target.

The insider sentiment on Columbia Care has been negative according to 76 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

David Hart’s trades have generated a 105.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Columbia Care, Inc. engages in the cultivation, manufacture and provision of medical cannabis products and services. It distributes its products under the EleCeed, TheraCeed, and ClaraCeed brands. The company was founded by Nicholas Vita and Michael Abbott in 2012 and is headquartered in New York, NY.